Efficacy and safety of levilimab in the treatment of rheumatoid arthritis in real-life clinical practice: first results of the HELIOS observational study by A. M. Lila, I. Z. Gaydukova, O. N. Anoshenkova, I. G. Bannikova, I. B. Vinogradova, M. L. Goldman, S. Yu. Davidian, L. P. Evstigneeva, O. E. Epifanova, E. V. Zemerova, A. I. Zagrebneva, L. V. Ivanova, A. K. Karibova, I. V. Menshikova, O. N. Mironenko, M. P. Mikhailova, N. E. Nikulenkova, I. M. Patrikeeva, T. V. Plaksina, G. R. Savvina, R. R. Samigullina, L. E. Sarantseva, J. V. Usacheva, O. P. Ukhanova, G. F. Fatkhullina, A. L. Chudinov, I. A. Shafieva, S. P. Yakupova

Subjects: Get full text

High efficacy and retention rate of levilimab in the treatment of patients with rheumatoid arthritis in real-life practice by A. I. Zagrebneva, E. N. Simonova, Yu. A. Gavrikova, V. V. Dolgov, G. A. Togizbayev

Subjects: Get full text

Steroid-sparing effect of levilimab in rheumatoid arthritis in real practice by Larisa V. Ivanova, Ekaterina Yu. Akulinushkina, Anastasia N. Vedekhina, Nuriya A. Garaeva, Aliya B. Rashitova, Nikita M. Taratorkin

Subjects: Get full text

Interleukin 6 receptor inhibitors in the treatment of rheumatoid arthritis during the COVID-19 pandemic, Moscow experience by A. I. Zagrebneva, E. N. Simonova, T. V. Mezenova, N. B. Burmistrova, Yu. A. Gavrikova, Yu. A. Gavrikova, E. O. Morozova, Zh. M. Kodzeva, K. S. Sapogina

Subjects: Get full text

Dynamics of modified cardiovascular risk factors in patients with rheumatoid arthritis on the background of 5-year therapy with an interleukin 6 receptor inhibitor by E. V. Gerasimova, T. V. Popkova, I. G. Kirillova, D. A. Gerasimova, E. L. Nasonov

Subjects: “…interleukin 6 receptor inhibitor…”
Get full text

Dynamics of traditional modifiable risk factors, total cardiovascular risk, and structural changes of carotid arteries in patients with rheumatoid arthritis on long-term interleuki... by E. V. Gerasimova, T. V. Popkova, A. V. Martynova, I. G. Kirillova, E. I. Markelova, A. S. Semashko, A. M. Lila, E. L. Nasonov

Subjects: “…interleukin-6 receptor inhibitor…”
Get full text

B-lymphocyte subpopulations in patients with rheumatoid arthritis and the effect of an interleukin-6 receptor inhibitor on them. by E. V. Gerasimova, T. V. Popkova, A. P. Aleksankin, A. V. Martynova, E. L. Nasonov

Subjects: Get full text